Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
Trials
|
March 12, 2026
Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trial
Julia Kopanz, Mira G P Zuidgeest, Linda Rutgrink, et al.
Drug Discovery Today
|
September 16, 2024
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches
Amos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
Pharmacoepidemiology and Drug Safety
|
February 13, 2014
Guideline-recommended use of asthma medication by children is associated with parental information and knowledge: the PIAMA birth cohort
Alet H Wijga, Mira G P Zuidgeest, Marjan Kerkhof, et al.
Contemporary Clinical Trials
|
December 18, 2022
Validation of the GetReal Trial Tool - Facilitating discussion and understanding more pragmatic design choices and their implications
Daniel Boateng, Thomas Kumke, Robin Vernooij, et al.
BMJ Open
|
August 29, 2022
Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov
Amos J de Jong, Renske J Grupstra, Yared Santa-Ana-Tellez, et al.
Journal of Clinical Epidemiology
|
May 28, 2017
Series: Pragmatic trials and real world evidence: Paper 1. Introduction
Mira G P Zuidgeest, Iris Goetz, Rolf H H Groenwold, et al.
BMC Medical Ethics
|
April 24, 2025
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groups
Tessa I van Rijssel, Johannes J M van Delden, Bart Lagerwaard, et al.
Clinical and Translational Science
|
November 22, 2024
What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?
Julia Kopanz, Bart Lagerwaard, Magdalena Beran, et al.
British Journal of Clinical Pharmacology
|
July 13, 2023
Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers
Amos J de Jong, Yared Santa-Ana-Tellez, Mira G P Zuidgeest, et al.
BMJ Open
|
November 5, 2025
Do people prefer to take part in a clinical trial from home or come to site? A discrete choice experiment in type 2 diabetes mellitus
Julia Kopanz, Bart Lagerwaard, Jorien Veldwijk, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
Trials
|
March 12, 2026
Participant satisfaction across three trial arms with varying degrees of decentralisation in the RADIAL proof-of-concept trial
Julia Kopanz, Mira G P Zuidgeest, Linda Rutgrink, et al.
Drug Discovery Today
|
September 16, 2024
Regulatory readiness to facilitate the appropriate use of innovation in clinical trials: The case of decentralized clinical trial approaches
Amos J de Jong, Mira G P Zuidgeest, Yared Santa-Ana-Tellez, et al.
Pharmacoepidemiology and Drug Safety
|
February 13, 2014
Guideline-recommended use of asthma medication by children is associated with parental information and knowledge: the PIAMA birth cohort
Alet H Wijga, Mira G P Zuidgeest, Marjan Kerkhof, et al.
Contemporary Clinical Trials
|
December 18, 2022
Validation of the GetReal Trial Tool - Facilitating discussion and understanding more pragmatic design choices and their implications
Daniel Boateng, Thomas Kumke, Robin Vernooij, et al.
BMJ Open
|
August 29, 2022
Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov
Amos J de Jong, Renske J Grupstra, Yared Santa-Ana-Tellez, et al.
Journal of Clinical Epidemiology
|
May 28, 2017
Series: Pragmatic trials and real world evidence: Paper 1. Introduction
Mira G P Zuidgeest, Iris Goetz, Rolf H H Groenwold, et al.
BMC Medical Ethics
|
April 24, 2025
Diversity in decentralized clinical trials: prioritizing inclusion of underrepresented groups
Tessa I van Rijssel, Johannes J M van Delden, Bart Lagerwaard, et al.
Clinical and Translational Science
|
November 22, 2024
What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?
Julia Kopanz, Bart Lagerwaard, Magdalena Beran, et al.
British Journal of Clinical Pharmacology
|
July 13, 2023
Direct-to-participant investigational medicinal product supply in clinical trials in Europe: Exploring the experiences of sponsors, site staff and couriers
Amos J de Jong, Yared Santa-Ana-Tellez, Mira G P Zuidgeest, et al.
BMJ Open
|
November 5, 2025
Do people prefer to take part in a clinical trial from home or come to site? A discrete choice experiment in type 2 diabetes mellitus
Julia Kopanz, Bart Lagerwaard, Jorien Veldwijk, et al.
Page
of 4